Published in Otolaryngol Pol on January 01, 2000
Transcription of full-length and truncated mRNA transcripts to study protein translocation across the endoplasmic reticulum. Methods Cell Biol (1991) 1.40
Comparative analysis of pollen counts of Corylus, Alnus and Betula in Szczecin, Warsaw and Lublin (2000-2001). Ann Agric Environ Med (2001) 1.05
X-linked hypophosphatemia in Polish patients. 1. Mutations in the PHEX gene. J Appl Genet (2000) 0.85
X-linked hypophosphatemia in Polish patients. 2. Analysis of clinical features and genotype-phenotype correlation. J Appl Genet (2001) 0.82
SLOS carrier frequency in Poland as determined by screening for Trp151X and Val326Leu DHCR7 mutations. Eur J Med Genet (2006) 0.82
Novel c.191C>G (p.Pro64Arg) MPV17 mutation identified in two pairs of unrelated Polish siblings with mitochondrial hepatoencephalopathy. Clin Genet (2013) 0.78
Biosynthesis and secretion of several enzymes in Escherichia coli dnaK and dnaJ mutants. Microbios (2000) 0.77
Antibiotic susceptibility of Escherichia coli dnaK and dnaJ mutants. Microb Drug Resist (2000) 0.76
[Comparative evaluation of diagnostic skin tests and blastic lymphocyte transformation in patients with asthma]. Pol Tyg Lek (1974) 0.75
[Trauma of the larynx and a method of treatment: case report]. Otolaryngol Pol (1997) 0.75
Occupational contact dermatitis, with asthma and rhinitis, from camomile in a cosmetician also with contact urticaria from both camomile and lime flowers. Contact Dermatitis (2003) 0.75
Susceptibility of primary and continuous cell lines to vaccinia virus. Arch Immunol Ther Exp (Warsz) (1966) 0.75
[Cell response in the nasal mucosa in patients with hay fever during plant pollen season]. Otolaryngol Pol (1997) 0.75
[Evaluating the usefulness of tests from the 3M Diagnostics Systems and Biowhittaker firms in diagnosis of Lyme disease and Borreliosis]. Pneumonol Alergol Pol (1994) 0.75
[Evaluation of the efficiency and safety of the loratadine with pseudoephedrine combination drug in treatment of seasonal allergic rhinitis]. Pol Merkur Lekarski (1998) 0.75
[Selected biochemical tumor markers in clinical monitoring of head and neck neoplasm progression]. Otolaryngol Pol (1999) 0.75
[Attempted evaluation of the effect of tonsillectomy on the condition of the myocardium]. Wiad Lek (1969) 0.75
[Allergology in internet]. Pol Merkur Lekarski (2000) 0.75
[Behavior of selected immunologic factors during the course of surgical treatment for palatine tonsillitis]. Pneumonol Alergol Pol (1994) 0.75
[Evaluation of the differences in levels of immunoglobulin G, A,and M in the course of malignant head and neck tumors]. Otolaryngol Pol (1995) 0.75
[Concentration of pollen dust in the atmosphere of Poland]. Pneumonol Alergol Pol (1994) 0.75
[Perennial specific immunotherapy in pollen allergy]. Otolaryngol Pol (1997) 0.75
[Differences in assay sensitivity of selected tumor markers in head and neck neoplasms]. Otolaryngol Pol (1995) 0.75
[The role of aeroallergens monitoring in the allergological practice]. Otolaryngol Pol (1997) 0.75
[The value of gastrointestinal antigens in the monitoring of patients with malignant head neoplasms]. Pol Merkur Lekarski (1998) 0.75
[Intal in the treatment of atopic extrinsic bronchial asthma. I. Effect on the ventilatory function]. Gruzlica (1974) 0.75
[A case of objective tinnitus]. Otolaryngol Pol (1997) 0.75
[Use of "rinoflow" inhalation in treatment of paranasal sinusitis]. Pol Merkur Lekarski (1997) 0.75
[Assessment of active renin instead of plasma renin activity in the renin captopril test]. Pol Merkur Lekarski (1998) 0.75
[Influence of alphacalcidole on selected markers of the bone turnover in hemodialysed patients with secondary hyperparathyroidism]. Pol Merkur Lekarski (1998) 0.75
[T lymphocyte subpopulations OKT-4 and OKT-8 in patients with bronchial asthma]. Pol Tyg Lek (1987) 0.75
[Serum levels of tissue polypeptide antigen in patients with the head and neck cancer according to presence of metastases in lymph nodes]. Otolaryngol Pol (2000) 0.75
[Surgical treatment of rhinophyma using CO2 laser]. Otolaryngol Pol (1999) 0.75
[Syntaris in the treatment of rhinitis]. Otolaryngol Pol (1994) 0.75
The interdependence of allergy and infection in an homogeneous population of 478 young males. Pneumonol Alergol Pol (1992) 0.75
[Squamous cell carcinoma antigen for monitoring patients with head neoplasm]. Pol Merkur Lekarski (1999) 0.75
[Serum lipoproteins in subclinical hypothyroidism]. Pol Tyg Lek (1980) 0.75
[Effect of short-term administration of phenytoin on blood serum levels of thyroid hormones]. Pol Tyg Lek (1987) 0.75
[Rhinomanometry: a method of objective study of nasal patency]. Otolaryngol Pol (1997) 0.75
[Serum angiotensin converting enzyme (SACE) in patients with atopic bronchial asthma]. Pneumonol Alergol Pol (1991) 0.75
[Laser surgery and interferon in the treatment of laryngeal papilloma]. Otolaryngol Pol (1997) 0.75
[Pleomorphic adenoma of the parapharyngeal space: a case report]. Otolaryngol Pol (1998) 0.75
[Lymph nodes metastases as a first sign of cancer]. Otolaryngol Pol (2000) 0.75
[Morphological and functional studies of the upper gastrointestinal tract segment in patients with chronic renal failure. II. Gastric juice secretion and blood serum gastrin activity]. Pol Arch Med Wewn (1980) 0.75
Oral allergy syndrome with contact urticaria from cosmetic creams. Contact Dermatitis (1999) 0.75
[Sarcoidosis of the paranasal sinuses]. Otolaryngol Pol (1998) 0.75
[Use of long-acting drainage (sino-ject) in treatment of chronic maxillary sinusitis]. Pol Merkur Lekarski (1997) 0.75
[Atypical localization of polymorphic adenoma]. Otolaryngol Pol (1997) 0.75
[Bone turnover markers in diabetics treated with continuous ambulatory peritoneal dialysis]. Pol Arch Med Wewn (1999) 0.75
[The influence of antihistamine agents on reaction time]. Otolaryngol Pol (1997) 0.75
[Gastrointestinal cancer antigen and immunoglobulins G, A, M in patients with head cancer]. Otolaryngol Pol (1998) 0.75
[Evaluation of the relationship between chosen factors and results of whole body scintigraphy with 131I in patients with differentiated thyroid cancers]. Wiad Lek (2001) 0.75
[A case of laryngeal glandular cancer]. Otolaryngol Pol (1995) 0.75
[Non-Hodgkin's lymphoma: diagnostic problems]. Otolaryngol Pol (1997) 0.75
RSK2 mutation co-segregates with X-linked intellectual disability and attenuated Coffin-Lowry phenotype in a three-generation family. Clin Genet (2013) 0.75
[Serum lipoproteins in hypothyroidism]. Pol Tyg Lek (1978) 0.75
[Endoscopic surgery of the sinus: own experiences]. Otolaryngol Pol (1997) 0.75
[Diagnostic value of osteotropic bone scintigraphy in maxillary sinus diseases]. Pol Merkur Lekarski (1999) 0.75
[N2O cryotherapy in treating allergic rhinitis]. Pneumonol Alergol Pol (1993) 0.75
[Application of CO2 laser surgery in the treatment of rhinophyma]. Otolaryngol Pol (1997) 0.75
[Atopic rhinitis]. Otolaryngol Pol (1987) 0.75
[Morphological and functional studies of the upper gastrointestinal tract segment in patients with chronic renal failure. III. Effect of calcium on blood gastrin level and gastric juice secretion]. Pol Arch Med Wewn (1980) 0.75
[Effect of histamine on behavior of the rosette test in patients with pollinosis]. Pneumonol Alergol Pol (1994) 0.75
[The prophylaxis of allergic rhinitis]. Otolaryngol Pol (1997) 0.75
[Alpha-fetoprotein--diagnostic utility in squamous cell carcinoma of the head and neck]. Pol Merkur Lekarski (2001) 0.75
[Three month treatment with budesonide in patients with corticoid dependent bronchial asthma--personal experience]. Pol Tyg Lek (1991) 0.75
[Radioimmunologic tests in specific immunotherapy of atopic rhinitis]. Wiad Lek (1984) 0.75
[Specific IgE antibodies in the sera of patients with allergic rhinitis]. Otolaryngol Pol (1986) 0.75
[Nasal airflow and its objective evaluation]. Pneumonol Alergol Pol (1994) 0.75
[Tumor markers in monitoring of neoplasms]. Otolaryngol Pol (1997) 0.75